15 Days Price Change
(-90.00) (-27.69%) 5Y
The National Commodity & Derivatives Exchange Limited (NCDEX) is a prominent on-line commodities exchange, specializing in a diverse range of agricultural and non-agricultural derivative products. Established on April 23, 2003, as a public limited company, NCDEX began its operations on December 15, 2003. The Exchange transitioned to a deemed recognized stock exchange under the Securities Contracts (Regulation) Act, 1956, on September 28, 2015, regulated by the SEBI.
Mission: NCDEX serves as a reliable platform for price discovery and risk management, consistently offering a wide array of derivative products that meet the needs of various stakeholders in the commodity value chain.
Functions:
Key shareholders include Life Insurance Corporation of India (LIC), National Bank for Agriculture and Rural Development (NABARD), National Stock Exchange of India Limited (NSE), Canara Bank, Punjab National Bank (PNB), and Indian Farmers Fertiliser Cooperative Limited (IFFCO). NCDEX's board of directors consists of experts in agricultural markets and derivatives.
NCDEX trades 23 permitted agricultural commodities, such as pulses, spices, and guar,
which are not commonly traded globally but hold economic significance for India.
This broad-based array positions NCDEX as a leading exchange for agricultural
derivatives.
Q1: What was the impact of commodity suspensions at the start of FY 2022-23 on NCDEX?
Q2: What was the Average Daily Traded Value (ADTV) for NCDEX in FY 2022-23?
Q3: How did the Average Daily Open Interest (ADOI) change in FY 2022-23 compared to the previous year?
Q4: How did the ADTV for continuing contracts change in FY 2022-23?
Q5: What does the increase in Open Interest indicate?
Q6: What percentage of the Exchange's volumes were previously contributed by suspended commodities?
Q7: What was the impact on deposits and deliveries due to the loss of suspended contracts?
This Q&A format summarizes the key points regarding the performance and challenges faced by NCDEX in FY 2022-23
Q1FY2025 Results of NCDEX
Particulars (In Cr) | Q1FY25 | Q1FY24 |
Revenue From Operations | 17 | 24 |
Employees Benefit Expenses | 24 | 23 |
Technology Expenses | 11 | 10 |
Other Expenses | 6 | 6 |
EBITDA | -24 | -15 |
OPM (%) | -141.18% | -62.50% |
Other Income | 7 | 7 |
Depreciation | 5 | 6 |
Finance Cost | 0.29 | 0.32 |
Exceptional Income | 48 | 0 |
Share of Net Profit from JV and other | 3 | 2 |
PBT | 29 | -13 |
Tax | 6 | -3 |
PAT | 23 | -10 |
NPM (%) | 95.83% | -32.26% |
EPS (₹) | 4.5 | -1.9 |
P&L Statement | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
Revenue | 113 | 115 | 104 | 96 |
Cost of Material Consumed | 0 | 0 | 11 | 0 |
Gross Margins | 100 | 100 | 89.42 | 100 |
Change in Inventory | 0 | 0 | 0 | 0 |
Employee Benefit Expenses | 72 | 81 | 88 | 91 |
Other Expenses | 75 | 69 | 71 | 70 |
EBITDA | -34 | -35 | -66 | -65 |
OPM | -30.09 | -30.43 | -63.46 | -67.71 |
Other Income | 39 | 45 | 35 | 58 |
Finance Cost | 1 | 2 | 1.5 | 1.3 |
D&A | 25 | 24 | 25 | 25 |
EBIT | -59 | -59 | -91 | -90 |
EBIT Margins | -52.21 | -51.3 | -87.5 | -93.75 |
PBT | -21 | -17 | -58 | -33 |
PBT Margins | -18.58 | -14.78 | -55.77 | -34.37 |
Tax | -7 | -5 | -16 | -5 |
PAT | -14 | -12 | -42 | -28 |
NPM | -12.39 | -10.43 | -40.38 | -29.17 |
EPS | -2.76 | -2.37 | -8.29 | -5.52 |
Financial Ratios |
2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
Operating Profit Margin | -30.09 | -30.43 | -63.46 | -67.71 |
Net Profit Margin | -12.39 | -10.43 | -40.38 | -29.17 |
Earning Per Share (Diluted) | -2.76 | -2.37 | -8.29 | -5.52 |
Assets | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
Fixed Assets | 13 | 10 | 8 | 43 |
CWIP | 0 | 0 | 0 | 4 |
Investments | 79 | 36 | 88 | 113 |
Trade Receivables | 31 | 29 | 32 | 23 |
Inventory | 0 | 0 | 0 | 0 |
Other Assets | 954 | 856 | 748 | 658 |
Total Assets | 1077 | 931 | 876 | 841 |
Liabilities | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
Share Capital | 50.68 | 50.68 | 50.68 | 50.68 |
FV | 10 | 10 | 10 | 10 |
Reserves | 456 | 455 | 424 | 425 |
Borrowings | 0 | 0 | 0 | 0 |
Trade Payables | 12 | 11 | 9 | 9 |
Other Liabilities | 558.32 | 414.32 | 392.32 | 356.32 |
Total Liabilities | 1077 | 931 | 876 | 841 |
Cash-Flow Statement | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
PBT | -21 | -17 | -58 | -33 |
OPBWC | -24 | -23 | -62 | -52 |
Change in Receivables | 1 | 1 | -3 | 8.6 |
Change in Inventories | 0 | 0 | 0 | 0 |
Change in Payables | -3 | -5 | 0 | 0.3 |
Other Changes | 91 | -146 | -31 | 6.1 |
Working Capital Change | 89 | -150 | -34 | 15 |
Cash Generated From Operations | 65 | -173 | -96 | -37 |
Tax | 29 | -8 | -1 | -18 |
Cash Flow From Operations | 94 | -181 | -97 | -55 |
Purchase of PPE | -13 | -14 | -14 | -12 |
Sale of PPE | 0 | 1 | 0 | 1 |
Cash Flow From Investment | 48 | 52 | 97 | 96 |
Borrowing | 0 | 0 | 0 | 0 |
Divided | -1.88 | -2.42 | -2.28 | 0 |
Equity | 0.06 | 0.03 | 0.05 | 0 |
Others From Financing | -8.18 | -5.61 | -5.77 | -6 |
Cash Flow from Financing | -10 | -8 | -8 | -6 |
Net Cash Generated | 132 | -137 | -8 | 35 |
Cash at the Start | 121 | 253 | 72 | 64 |
Cash at the End | 253 | 116 | 64 | 99 |
Particulars (cr) | Revenue (Fy24) | PAT (Fy24) | P/E (17/01/2025) | Mcap (17/01/2025) |
NCDEX | 96 | -29 | NA | 1500 Cr |
MCX | 684 | 83 | 88x | 30000 Cr |